醫療器械美華國際:靠一副“口罩”撐起IPO
受疫情影響,部分醫療設備需求大幅增長,醫療器械成了“香餑餑”。
互聯網巨頭魚貫而入醫療賽道,垂直醫療領域企業尋求上市獲得資本青睞。
日前,美華國際醫療科技有限公司(簡稱“美華國際醫療”)正式向美國證券交易委員會(SEC)遞交招股書,計劃在納斯達克上市,股票代碼“MHUA”。Prime Number Capital、申港證券爲其聯席承銷商。
美華國際醫療是家一次性醫療器械供應商,截至招股書發佈之日,其產品在國內的滲透已通過近2095家經銷商、473家醫院和醫療機構的直銷方式,滲透到各大醫療機構和藥店。
進入後疫情時代,醫療器械賽道發展將會向何方發展?美華國際醫療赴美上市有何看點?美股研究社通過解讀關鍵信息,或許能夠讓外界對其有更多的認知。
IPO計劃募資6900萬美元,主打“口罩”醫療器械
美華國際醫療來自江蘇揚州,成立於1990年。
美華國際醫療銷售途徑分內銷與外銷,內銷產品具有800多種,外銷出口產品具有120多種。出口產品延伸至歐洲、北美、南美、亞洲、非洲和大洋洲等大洲的 30 多個國家。
主要產品包括一次性使用輸注泵、麻醉穿刺包、電子泵、全麻包、導尿包、婦檢包、氣管插管、敷料敷貼、各種管類等一、二、三類產品。在ID手環、手術膠帶、彈力繃帶等產品中,有20多種爲FDA I 類產品,排名前2的產品爲“醫用敷料”和“口罩”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.